Toggle navigation
Menu
About Us
Investment Strategy
Team
Portfolio
News
Contact Us
Limited Partners
Portfolio
MediciNova, Inc.
Focuses on acquiring and developing novel, small-molecule therapeutics for the US market
La Jolla, CA
NASDAQ: MNOV
Contact:
Jeff Himawan
www.medicinova.com
Related News
MediciNova, Inc. Announces Private Sale of Stock to Kissei Pharmaceutical Co., Ltd.
Joint Venture Announced: MediciNova, Inc. and Zhejiang Medicine Co., Ltd. to Partner in China
Chinese Joint Venture Completed
Medicinova Gets Green Light for MS Trial
